Be part of our team

As a Clinical Scientist and member of our Clinical Development team, you will support the planning and execution of full life-cycle development of our antibody-drug conjugates (ADCs) global clinical trials. You will support the review, analysis, and interpretation of clinical trial data, contribute to the development of critical clinical trial documents, and take an active role in risk monitoring and mitigation. You will be part of a highly collaborative and cross-functional team involved with site evaluation, study start-up, study execution and management, and study close-out of our trials. 

This position will report to the VP, Clinical and Translational Development. The ideal candidate will be based in the Boston, MA region with remote opportunities available for candidates located in MA, NY, PA, RI, NC, CA. Must be able to work East Coast hours.

Your mission

• Support the Medical Director in the oversight of clinical studies including review and interpretation of clinical trial data and timely execution of deliverables in collaboration with relevant internal and external partners.
• Take a lead role in writing protocol amendments, informed consents, and other protocol-related documents for the operational execution of clinical studies.
• Participate in the start-up of global clinical studies, working with Clinical Operations to ensure on schedule site activation and subject enrollment, monitoring, compliance with safety practices, policies, procedures as well as the day-to-day management of a clinical trial. 
• Implement clinical study parameters, deliverables, policy compliance and resource needs.
• Actively identify areas of emerging risk for the execution of clinical studies and proposing solutions to minimize and mitigate risk. These may include meeting timelines in site activation, enrollment, identifying shortcomings or delays in data entry at clinical sites, and ensuring the timely execution of responses to regulatory interactions.
• Play a key role in the review of study data to ensure timely and high-quality data entry, including review of case report forms, assists in coding, analysis, and proper and complete documentation of clinical data.
• Participate in investigator meetings, investigator engagement, including assisting in the preparation of Advisory Board meetings.
• Support the Medical Director in managing sites to ensure study treatment discontinuation or other safety decisions are made per protocol and align with stakeholders within the study team.
• Support the Medical Director to coordinate relevant and timely data analyses and presentations in collaboration with safety, data management, Data Monitoring Committee, Biostatistics, Pharmacometrics and Biomarker teams to meet timelines for safety monitoring committee meetings, regulatory documents and to internal reviews to make timely program decisions regarding study objectives.
• Participate in the training of site and company staff on the study protocol, ensure the clinical staff have the necessary guidance

Your profile

Qualifications:

• A minimum of 3 years of experience as a clinical scientist supporting interventional studies in oncology (biotech/pharma/CRO) is required.
• BS or BSN is minimally required. An advanced degree in a scientific discipline (i.e. MS, PharmD, PhD, MD) is preferred.
• Strong knowledge in clinical development in Oncology development is required.
• Significant experience with clinical evaluation projects including development of protocols, case report forms, informed consent and study initiation and monitoring.
• Understanding of good clinical practice (GCP) for execution and evaluation of clinical trials.
• Significant experience with data integrity, exploration, analysis and presentation.
• High-performing and energetic individual who demonstrates outstanding scientific knowledge applicable to early disease clinical research and the highest personal and ethical standards.
• Must be equally comfortable among the team to which he/she is assigned and in the global environment in which the Company operates.
• Requires capabilities to work on additional studies moving into operation in later years. This will involve close interaction and working closely with the discovery, biomarkers, clinical pharmacology, pharmacometrics, regulatory, biostatistics, clinical operations and Clinical Development.
• Hold a strong understanding how these various functions work, the Clinical Scientist should be capable of implementing translational medicine approaches for clinical development. 
• Proactive team player, results-oriented, and striving to find best solutions in a collegial team environment.
• Self-organized, self-motivated, and able to work independently.
• Excellent written communication, oral communication, and presentation skills are required.

Preferred Qualifications:

• Detailed understanding of risk-based safety monitoring and familiarity with Common Terminology Criteria for Adverse Events (CTCAE).
• Facility with Microsoft excel for data review and analysis.
• Expertise in programming in R.

Why us?

At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.

• Impact that matters: Contribute to breakthrough therapies.
• Global mindset: Work in an international, diverse team.
• Grow & thrive: Develop your career in a supportive, fast-moving environment.
• Innovation every day: Push boundaries with cutting-edge science.

At Tubulis, your ideas matter, your growth matters—and together, we make a difference.

About us

The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and antibody-drug conjugates (ADCs). With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.